Matinas Biopharma Holdings Inc. (MTNB) Climbed 9.22% or 0.08 To Price $0.95 On Friday


Matinas Biopharma Holdings Inc. (MTNB) climbed 9.22% or 0.08 to $0.95. It is close to 972263 shares traded, which is 113.9% compare to the average total volume 853637. The market cap of MTNB is $106.79 million. The year to date change is 51.84%. The 52 week price range is from $0.32 to $1.48. Price of MTNB have changed 45.27% during last week. It have changed 16.00% over last month, 19.18% over last 3 months, 112.20% over last 6 months and -32.56% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for MTNB is 0.75. It is -21.05% below current price. The 200-day Moving Averages for MTNB is 0.61. It is -35.79% below current price. The 52-week High is 1.48. It is 55.79% from the current price. The 52-week Low is 0.32. It is -66.32% from current price.

Some people may be interesting about short interest ratio of a stock. The short interest ratio of MTNB is 3.64 on 2018-12-14. Short % to float is 3.87%. There are some statistics of MTNB. It is has market cap $106.79 million. The share outstanding is 112.39 million. The average volume is 853637. The percent of top 15 Institution holding is 10.20%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of MTNB is -524.74%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of MTNB is -96.13%.


Tags:

Share this post